|
|
|
|
||
Re: Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the 13th Clinical Trials on Alzheimer's Disease (CTAD) ConferenceMeeting: Thats a whole lot of DRP stuff to digest! Is this a driver of the rise in the PPS RECENTLY and not just a quarterly reporting? 44.00 looks in THE FAR distance in the rear view mirror. Lets hope it stays there! JMO kutz |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
17154 | Re: Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the 13th Clinical Trials on Alzheimer's Disease (CTAD) Conference | JBird61 | 9 | 10/27/2020 11:13:53 AM |